In case 6, the ALCL lost a large part of 17p, including TP53. The PCL had gains in 1q, as is typical for plasma cell malignancies and lost 13q, which encompassed the tumor suppressor genes BRCA2 and RB1. Here, RB1 is linked to plasma cell leukemia.